This case uses a straightforward market analysis approach to evaluate a new product launch decision. The candidate must calculate market sizing, conduct financial modeling across product lines, and assess whether the higher-margin antiviral segment justifies strategic pivot. The case emphasizes quantitative rigor combined with competitive positioning logic.